Audit target · February 5, 2026
Modifier 25 Downcoding: What Payers Are Automating Now
Modifier 25 is the most examined modifier in dermatology because same-day procedures are the norm here rather than the exception. Several large commercial plans now reduce the E/M automatically when a procedure is on the same claim, before any human reviews the note.
This update changes the standing rules set out in our guide to modifier 25 in dermatology, which is where the evergreen coding logic lives.
What triggers the automated reduction
- An office E/M billed with a destruction, biopsy or excision on the same date, with no distinct diagnosis linked to the E/M line.
- A note where the history and exam read as pre-procedure evaluation rather than a separate problem.
- Repeated modifier 25 use at a rate far above the specialty norm across a single rendering provider.
What actually defends the claim
The defensible pattern is simple to state and harder to enforce: the note must show a separately identifiable problem that was evaluated and for which a decision was made, distinct from the decision to perform the procedure. A patient who arrives for a scheduled lesion removal and receives only that removal does not support modifier 25. The same patient who also raises a new rash, is examined for it and receives a management plan does.
We do not append modifier 25 to make a claim pay. Where the note does not support it, we tell the provider what was missing, because a paid claim that cannot survive a post-payment review is a liability rather than revenue.
Appealing a downcode
- Appeal with the note, not a letter. The note either shows the separate service or it does not.
- Point to the distinct diagnosis linked to the E/M line and the separate management decision in writing.
- Track downcode rates by payer and by provider monthly; a rising rate for one payer is a policy change, a rising rate for one provider is a documentation problem.
Frequently asked questions
Should we just stop using modifier 25?
No. Dropping it where it is supported gives away legitimate revenue on a large share of visits. The correct response is a documentation standard that makes the separate service visible in the note, plus an appeal process for automated reductions.
Does a different diagnosis code guarantee payment?
It helps, but no. A distinct diagnosis linked to the E/M line supports the claim; the note still has to show the separate evaluation and decision behind that diagnosis.
More updates
- Skin Substitute Application Codes: What Changed for 2026
- 2026 Fee Schedule: Conversion Factor and Dermatology RVU Shifts
- Biologic and JAK Inhibitor Prior Authorization Is Tightening
- Dermatopathology TC/26 Splits and Place-of-Service Edits
- Mohs Stage Counts and Repair Sequencing Under Post-Payment Review
Have us apply this change for you
Coding changes only matter once they reach the claim build. Our coding team maintains these rules per payer so a policy change does not land as next quarter's denial batch.